American Oriental Bioengineering Inc. (AOB) is “One to Watch”
Today, we are adding American Oriental Bioengineering Inc. to our China “One’s to Watch” list. Together with its subsidiaries, the company engages in the development, manufacture, and commercialization of a range of pharmaceutical and healthcare products. Based in Shenzhen, China, the company has a market capitalization of approximately $400 million. The company provides more than 30 over-the-counter type drugs, and conducts its own research, development, production, and distribution of more than 40 pharmaceutical products. Currently all of their products are approved by the Chinese State Food and Drug Administration (SFDA). In the pipeline, American Oriental has over 400 SFDA approved…
